lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
9beta,11beta-epoxy-17alpha,21-dihydroxy-16beta-methylene-pregna-1,4-diene-3,20-dione basic information |
product name: | 9beta,11beta-epoxy-17alpha,21-dihydroxy-16beta-methylene-pregna-1,4-diene-3,20-dione |
synonyms: | 16-beta methyl epoxide;9beta,11beta-epoxy-17alpha,21-dihydroxy-16beta-methylene-pregna-1,4-diene-3,20-dione;db11;(9β)-9,11β-epoxy-16β-methyl-17,21-dihydroxypregna-1,4-diene-3,20-dione;9β,11β-epoxy-17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione;einecs 213-563-4;betamethasone 9,11-epoxide;9beta,11beta-epoxy-1 |
cas: | 981-34-0 |
mf: | c22h28o5 |
mw: | 370.44 |
einecs: | 213-563-4 |
product categories: | intermediates & fine chemicals;metabolites & impurities;pharmaceuticals;steroids |
mol file: | 981-34-0.mol |
9beta,11beta-epoxy-17alpha,21-dihydroxy-16beta-methylene-pregna-1,4-diene-3,20-dione chemical properties |
mp | 210-220 ºc |
storage temp. | refrigerator |